@article{493cb305d3c946f0a9b056034fee7410,
title = "MM-155: Phase 3 MAIA Study: Overall Survival (OS) Results with Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) vs Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (TIE-NDMM)",
author = "Orlowski, {Robert Z} and Thierry Facon and Kumar, {Shaji K.} and Torben Plesner and Philippe Moreau and Bahlis, {Nizar J} and Supratik Basu and Hareth Nahi and Cyrille Hulin and Hang Quach and Hartmut Goldschmidt and Michael O'Dwyer and Aurore Perrot and Venner, {Christopher P.} and Katja Weisel and Mace, {Joseph R.} and Noopur Raje and Mourad Tiab and Margaret Macro and Laurent Frenzel and Xavier Leleu and Tahamtan Ahmadi and Jianping Wang and {Van Rampelbergh}, Rian and Clarissa Uhlar and Brenda Tromp and Maria Delioukina and Jessica Vermeulen and Usmani, {Saad Z}",
year = "2021",
doi = "10.1016/S2152-2650(21)01581-0",
language = "English",
volume = "21",
journal = "Clinical Lymphoma Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Elsevier",
number = "Suppl. 1",
note = "The ninth annual meeting of the Society of Hematologic Oncology ; Conference date: 08-09-2021 Through 11-09-2021",
}